Catenin beta-1 mRNA (CTNNB1 mRNA)

Catenin beta-1 (CTNNB1) mRNA is the transcript responsible for the synthesis of the beta-catenin protein, a key mediator in the canonical Wnt signaling pathway and a structural component of cadherin-based cell-cell adhesion (UniProt: P35222). In the absence of Wnt ligands, beta-catenin protein is typically degraded; however, mutations in the CTNNB1 gene or upstream components like APC can lead to its stabilization and nuclear translocation (NCBI Gene: 1499). Once in the nucleus, beta-catenin acts as a transcriptional co-activator, driving the expression of oncogenes such as MYC and CCND1. Because the beta-catenin protein lacks traditional small-molecule binding pockets, targeting its mRNA using RNA interference (RNAi) or antisense oligonucleotides (ASOs) has emerged as a viable therapeutic strategy (PubMed: 28811280). These approaches, such as AZD4785 and DCR-BCAT, aim to reduce the overall pool of beta-catenin protein to inhibit tumor growth and progression in Wnt-driven malignancies like hepatocellular carcinoma and colorectal cancer (PubMed: 27535150). However, therapeutic development must carefully balance efficacy with the potential for systemic toxicity, as Wnt signaling is essential for normal tissue homeostasis and regeneration in the gut and bone.

Other names

Beta-catenin mRNACTNNB1 mRNACatenin (cadherin-associated protein), beta 1, mRNACTNNB1 transcript

Antisense oligonucleotide-mediated RNase H cleavage and RNA interference (RNAi) leading to mRNA degradation and reduced protein translation (PubMed: 28811280, 27535150).